Xerox reverses course, says its CEO and majority of the board are staying, after agreement with shareholders opposing a buyout by Fujifilm expired on Thursday
Context & Ripple Effects
Two days earlier, Xerox had announced that its chairman, CEO, and a majority of the board would leave in favor of allies of Carl Icahn and Darwin Deason, the shareholders fighting the Fujifilm merger (the board-clearing announcement). This reversal — keeping the CEO and most directors once the standstill agreement with those shareholders expired — reads as a countermove in that fight rather than a resolution.
It did not hold: within two weeks Xerox reached a deal with Icahn and Deason and called off the Fujifilm sale entirely (the termination deal), prompting Fujifilm to sue for $1B+ (that lawsuit). The episode matters because it shows an activist pair converting board pressure into full control of a century-old company's strategic direction.
First-order effects
- Xerox's CEO and majority of directors keep their seats for now, while Icahn and Deason lose the immediate lever their expiring agreement gave them over board composition.
- Fujifilm's pending buyout loses its path to a friendly close, since the leadership team that negotiated it survives instead of being replaced by merger opponents' allies.
Second-order effects
- With the incumbents entrenched again, the activists' remaining route is a fresh settlement or proxy campaign — which is exactly where this lands when Xerox strikes a deal with Icahn and Deason that kills the Fujifilm transaction.
- Fujifilm is left holding a signed merger framework with a counterparty now signaling it may walk, setting up the litigation and eventual unwind of their joint-venture arrangement.
Third-order effects
- The pattern here — activists forcing out a board, management reversing, then a settlement handing them effective control — became the template for how Xerox's strategy was set for years, from abandoning Fujifilm to launching and then dropping the HP bid.
- For legacy hardware companies, the episode signals that large shareholders can override signed cross-border mergers, raising the bar for any acquirer whose deal depends on incumbent-board approval alone.
The trend: Activist investors are displacing incumbent boards as the decisive power in legacy-tech M&A, turning signed mergers into negotiable starting points rather than done deals.